Vice-President

Medicine & Life Sciences

1. Pemphigus 100%
2. Esophageal Neoplasms 99%
3. Rheumatoid Arthritis 96%
4. Esophagectomy 75%
5. Japan 68%
6. Stomach Neoplasms 58%
7. Esophageal Squamous Cell Carcinoma 57%
8. Desmoglein 3 57%
9. Neoplasms 55%
10. Neoplasm Metastasis 45%
11. Therapeutics 40%
12. Methotrexate 39%
13. Safety 37%
14. Lymph Nodes 34%
15. Autoantibodies 34%
16. Survival 33%
17. Recurrence 32%
18. Sentinel Lymph Node 31%
19. Immunoglobulin G 29%
20. Drug Therapy 29%
21. Liver Transplantation 29%
22. Desmoglein 1 28%
23. Skin 28%
24. Colorectal Neoplasms 28%
25. Chemoradiotherapy 26%
26. Desmogleins 24%
27. Liver 24%
28. Serum 24%
29. Living Donors 24%
30. Cisplatin 23%
31. tocilizumab 23%
32. Gastrectomy 23%
33. Fluorouracil 22%
34. Antibodies 21%
35. Laparoscopy 21%
36. Spine 20%
37. Joints 20%
38. Bullous Pemphigoid 19%
39. Lymph Node Excision 19%
40. Thorax 19%
41. Breast Neoplasms 19%
42. Pancreatic Neoplasms 19%
43. Stomach 19%
44. Transplants 18%
45. Retrospective Studies 17%
46. baricitinib 17%
47. Placebos 17%
48. Adalimumab 17%
49. Systemic Lupus Erythematosus 17%
50. Incidence 16%
51. Postoperative Complications 16%
52. Antirheumatic Agents 16%
53. Gastrointestinal Neoplasms 15%
54. Coronavirus 15%
55. Cohort Studies 15%
56. Blister 15%
57. Adenocarcinoma 14%
58. T-Lymphocytes 14%
59. Immunoglobulin G4-Related Disease 14%
60. Carcinoma 14%
61. Knee 14%
62. Genes 14%
63. Ossification of Posterior Longitudinal Ligament 14%
64. Biomarkers 14%
65. Spinal Cord 14%
66. Atopic Dermatitis 14%
67. Autoimmune Diseases 13%
68. Keratinocytes 13%
69. Hepatocellular Carcinoma 13%
70. Esophagus 13%
71. Surgical Wound Infection 12%
72. Multicenter Studies 12%
73. Laminoplasty 12%
74. Bone and Bones 12%
75. Infliximab 12%
76. Anastomotic Leak 12%
77. Antigens 12%
78. Databases 12%
79. Prospective Studies 12%
80. B-Lymphocytes 12%
81. Docetaxel 12%
82. Spinal Cord Diseases 12%
83. Abatacept 12%
84. Systematic Reviews 11%
85. Confidence Intervals 11%
86. Pneumonia 11%
87. filaggrin 11%
88. Nivolumab 11%
89. Magnetic Resonance Imaging 11%
90. Tomography 11%
91. Phenotype 11%
92. Anti-Idiotypic Antibodies 11%
93. Infections 11%
94. Neoadjuvant Therapy 11%
95. C-Reactive Protein 11%
96. Squamous Cell Carcinoma 10%
97. Lung 10%
98. Autoantigens 10%
99. Proteins 10%
100. peficitinib 10%